Non-Applicability of Annual Secretarial Compliance Report for the Financial Year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has informed BSE that the company is not required to submit an Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The exemption applies because the company qualifies as a Listed SME (Small and Medium Enterprise) entity. Under SEBI regulations, specifically Regulation 15(2)(b) of the SEBI (LODR) Regulations, 2015, Listed SME companies are exempt from certain compliance requirements including this secretarial audit report. The company is headquartered in Virar, Palghar and is listed on BSE with scrip code 539680. The intimation was signed by Managing Director Bharat Sharma on May 28, 2026.
No direct impact on shareholders — this is a routine compliance intimation confirming the company's exemption status as an SME-listed entity. The stock is not affected by this regulatory notification.